Published in Br J Pharmacol on July 01, 2005
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure. Neuropsychopharmacology (2009) 0.92
Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia. Psychopharmacology (Berl) (2007) 0.88
Glutamate receptors in the dorsal hippocampus mediate the acquisition, but not the expression, of conditioned place aversion induced by acute morphine withdrawal in rats. Acta Pharmacol Sin (2009) 0.81
The role of functional postsynaptic NMDA receptors in the central nucleus of the amygdala in opioid dependence. Vitam Horm (2010) 0.81
Glutamate mechanisms underlying opiate memories. Cold Spring Harb Perspect Med (2012) 0.80
Ultrastructural relationship between the AMPA-GluR2 receptor subunit and the mu-opioid receptor in the mouse central nucleus of the amygdala. Exp Neurol (2010) 0.79
Conditioned place preference induced by electrical stimulation of the insular cortex: effects of naloxone. Exp Brain Res (2013) 0.75
Monosodium glutamate-associated alterations in open field, anxiety-related and conditioned place preference behaviours in mice. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Glutamate receptor function in learning and memory. Behav Brain Res (2003) 2.72
Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons. Nature (1998) 2.24
Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci (2000) 1.73
Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol (1992) 1.63
Glutamatergic mechanisms in addiction. Mol Psychiatry (2003) 1.49
Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res (1995) 1.33
Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res (1991) 1.22
Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci (2002) 1.21
Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology (Berl) (2003) 1.15
Opiate withdrawal-induced fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology (2001) 1.13
Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem (1992) 1.08
Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res (1994) 1.06
Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol (2002) 1.02
Discrete quinolinic acid lesions of the rat prelimbic medial prefrontal cortex affect cocaine- and MK-801-, but not morphine- and amphetamine-induced reward and psychomotor activation as measured with the place preference conditioning paradigm. Behav Brain Res (1998) 1.01
Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.98
Acute physical dependence in man: effects of naloxone after brief morphine exposure. J Pharmacol Exp Ther (1988) 0.96
SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berl) (1989) 0.96
Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther (1990) 0.93
Effects of NMDA receptor antagonists on passive avoidance learning and retrieval in rats and mice. Psychopharmacology (Berl) (1990) 0.92
Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure. Psychopharmacology (Berl) (1997) 0.92
Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists. J Pharmacol Exp Ther (1997) 0.91
The aversive properties of acute morphine dependence persist 48 h after a single exposure to morphine: evaluation by taste and place conditioning. Pharmacol Biochem Behav (2002) 0.91
N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci Lett (1995) 0.91
Place conditioning with morphine and phencyclidine: dose dependent effects. Life Sci (1985) 0.91
Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine. Pharmacol Biochem Behav (1997) 0.89
Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem Int (2001) 0.86
The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci (1992) 0.85
The rewarding properties of NMDA and MK-801 (dizocilpine) as indexed by the conditioned place preference paradigm. Pharmacol Biochem Behav (1999) 0.85
A COMPARISON BETWEEN ACUTE AND CHRONIC PHYSICAL DEPENDENCE IN THE CHRONIC SPINAL DOG. J Pharmacol Exp Ther (1964) 0.84
The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology (Berl) (1996) 0.84
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J Pharmacol Exp Ther (1997) 0.84
Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal. Behav Brain Res (2003) 0.83
Role of the limbic system in dependence on drugs. Ann Med (1998) 0.83
Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) (2004) 0.83
Acute phencyclidine induces aversion, but repeated phencyclidine induces preference in the place conditioning test in rats. Eur J Pharmacol (1996) 0.81
Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav Pharmacol (1996) 0.81
Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology (Berl) (2003) 0.80
The effects of MK801 on place conditioning. Neurosci Res (1995) 0.80
The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol Biochem Behav (1994) 0.79
Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study. Pharmacol Biochem Behav (1998) 0.79
Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci (1994) 0.78
The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol Biochem Behav (1993) 0.78
Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol Biochem Behav (1996) 0.78
Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine. Eur J Pharmacol (1998) 0.78
Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists. Eur J Pharmacol (2000) 0.77
Neuronal mechanisms of phencyclidine-induced place aversion and preference in the conditioned place preference task. Methods Find Exp Clin Pharmacol (1998) 0.77
PCP and conditioned place preferences. Pharmacol Biochem Behav (1989) 0.77
Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats. Neurosci Lett (2003) 0.76
Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur J Pharmacol (1996) 0.76
Functional changes in neuronal systems induced by phencyclidine administration. Ann N Y Acad Sci (1996) 0.76
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol (2009) 21.94
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer (2009) 2.35
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell (2013) 2.32
EGFR mutation of tumor and serum in gefitinib-treated patients with chemotherapy-naive non-small cell lung cancer. J Thorac Oncol (2006) 1.75
PICK1 deficiency impairs secretory vesicle biogenesis and leads to growth retardation and decreased glucose tolerance. PLoS Biol (2013) 1.41
Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure. Drug Metab Pharmacokinet (2009) 1.41
Simple indole alkaloids and those with a nonrearranged monoterpenoid unit. Nat Prod Rep (2002) 1.26
Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci U S A (2007) 1.15
Royal jelly ameliorates insulin resistance in fructose-drinking rats. Biol Pharm Bull (2008) 1.12
Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004. J Thorac Oncol (2009) 1.12
In vivo characterization of high Basal signaling from the ghrelin receptor. Endocrinology (2009) 1.08
[Effects of practical training to increase motivation for learning and related factors]. Yakugaku Zasshi (2014) 1.04
CYP2C polymorphisms, phenytoin metabolism and gingival overgrowth in epileptic subjects. Life Sci (2004) 1.03
Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am J Kidney Dis (2002) 0.99
Infants with bronchopulmonary dysplasia suckle with weak pressures to maintain breathing during feeding. Pediatrics (2007) 0.99
Simple indole alkaloids and those with a non-rearranged monoterpenoid unit. Nat Prod Rep (2013) 0.96
Beneficial Effects of Fermented Green Tea Extract in a Rat Model of Non-alcoholic Steatohepatitis. J Clin Biochem Nutr (2009) 0.96
Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther (2005) 0.96
G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction. Endocrinology (2009) 0.96
Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br J Pharmacol (2004) 0.90
[Effect of propolis on insulin resistance in fructose-drinking rats]. Yakugaku Zasshi (2007) 0.89
Total Syntheses of Carazostatin, Hyellazole, and Carbazoquinocins B-F. J Org Chem (1997) 0.88
Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy. Hypertension (2002) 0.88
Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. Antimicrob Agents Chemother (2009) 0.88
Histamine-induced vasodilation and vasoconstriction in the mesenteric resistance artery of the rat. Eur J Pharmacol (2005) 0.88
One-pot construction of 3,3'-bisindolylmethanes through Bartoli indole synthesis. Org Lett (2013) 0.88
Neuronal nicotinic receptor and psychiatric disorders: functional and behavioral effects of nicotine. Jpn J Pharmacol (2002) 0.87
Regulation of ghrelin secretion during pregnancy and lactation in the rat: possible involvement of hypothalamus. Peptides (2004) 0.87
Hyperinsulinemia induces hypertension associated with neurogenic vascular dysfunction resulting from abnormal perivascular innervations in rat mesenteric resistance arteries. Hypertens Res (2011) 0.87
Anti-oxidative and anti-inflammatory effects of spirulina on rat model of non-alcoholic steatohepatitis. J Clin Biochem Nutr (2012) 0.87
A phase I study of carboplatin and docetaxel for advanced non-small cell lung cancer using the continual reassessment method. Jpn J Clin Oncol (2002) 0.85
A new approach for evaluating renal function and its practical application. J Pharmacol Sci (2007) 0.85
Pharmacological interplay between breast cancer resistance protein and gefitinib in epidermal growth factor receptor signaling. Anticancer Res (2009) 0.85
Relationship between the risk of falling and drugs in an academic hospital. Yakugaku Zasshi (2008) 0.85
Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiol Behav (2006) 0.85
Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.84
Factors producing a menopausal depressive-like state in mice following ovariectomy. Psychopharmacology (Berl) (2006) 0.84
Effects of physical and psychological stress on 5-HT2A receptor-mediated wet-dog shake responses in streptozotocin-induced diabetic rats. Acta Med Okayama (2007) 0.84
β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia. Int J Endocrinol (2011) 0.84
Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test. Pharmacol Biochem Behav (2002) 0.83
Extrauterine growth restriction in preterm infants of gestational age < or =32 weeks. Pediatr Int (2008) 0.83
Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors. Br J Pharmacol (2004) 0.83
Effects of mood stabilizers on the disruption of prepulse inhibition induced by apomorphine or dizocilpine in mice. Eur J Pharmacol (2006) 0.83
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes (2012) 0.83
Oral mucosal adhesive films containing royal jelly accelerate recovery from 5-fluorouracil-induced oral mucositis. J Pharmacol Sci (2013) 0.83
Withdrawal-induced c-Fos expression in the rat centromedial amygdala 24 h following a single morphine exposure. Psychopharmacology (Berl) (2004) 0.83
Repeated electroconvulsive stimuli have long-lasting effects on hippocampal BDNF and decrease immobility time in the rat forced swim test. Life Sci (2007) 0.82
Repeated electroconvulsive stimuli increase brain-derived neurotrophic factor in ACTH-treated rats. Eur J Pharmacol (2005) 0.82
A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin J Pain (2012) 0.82
A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH. J Clin Biochem Nutr (2009) 0.82
The mechanism of calcitonin gene-related peptide-containing nerve innervation. J Pharmacol Sci (2012) 0.82
Beneficial effects of Vitis coignetiae Pulliat leaves on nonalcoholic steatohepatitis in a rat model. Acta Med Okayama (2009) 0.82
A dibenzoylmethane derivative protects dopaminergic neurons against both oxidative stress and endoplasmic reticulum stress. Am J Physiol Cell Physiol (2007) 0.82
Identification of antidepressant-like ingredients in ginseng root (Panax ginseng C.A. Meyer) using a menopausal depressive-like state in female mice: participation of 5-HT2A receptors. Psychopharmacology (Berl) (2011) 0.81
Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit (2007) 0.81
[Involvement of the amygdala on place aversion induced by naloxone in single-dose morphine-treated rats]. Yakugaku Zasshi (2008) 0.81
Investigation of the release behavior of a covered-rod-type formulation using silicone. J Control Release (2003) 0.81
Nicotine attenuates place aversion induced by naloxone in single-dose, morphine-treated rats. Psychopharmacology (Berl) (2003) 0.80
Endothelial modulation of agonist-induced vasoconstriction in mesenteric microcirculation. Yakugaku Zasshi (2010) 0.80
Protective effects of interferon-gamma against methamphetamine-induced neurotoxicity. Toxicol Lett (2008) 0.80
Effect of heat exposure on aminophylline-induced convulsions in mice. Biol Pharm Bull (2011) 0.80
Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence. Behav Brain Res (2005) 0.80
New molecular mechanisms for cardiovascular disease: contribution of endothelium-derived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries. J Pharmacol Sci (2011) 0.80
Imipramine-induced c-Fos expression in the medial prefrontal cortex is decreased in the ACTH-treated rats. J Biochem Mol Toxicol (2013) 0.80